Olpruva
Payments companies reported to CMS as associated with Olpruva. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Olpruva, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Olpruva
These are the largest totals companies reported as associated with Olpruva. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Chiadikaobi Onyike | Baltimore, MD | Psychiatry | $11,700.00 |
| Caroline Hastings | Oakland, CA | Pediatric Hematology-Oncology | $3,950.00 |
| Paul Hillman | Houston, TX | Clinical Genetics (M.D.) | $3,449.54 |
| Sookyong Koh | Chicago, IL | Neurology With Special Qualifications In Child Neurology | $2,200.00 |
| Kristen Lancaster | Charleston, SC | Clinical Genetics (M.D.) | $1,844.85 |
| Elizabeth Berry-Kravis | Chicago, IL | Neurology With Special Qualifications In Child Neurology | $1,800.00 |
| Walla Al-Hertani | Orange, CA | Clinical Genetics (M.D.) | $1,749.00 |
| Dmitriy Niyazov | Durham, NC | Clinical Genetics (M.D.) | $1,680.00 |
| Paula Schleifer | Miami, FL | Neurology With Special Qualifications In Child Neurology | $1,650.00 |
| Vernon Sutton | Houston, TX | Pediatrics | $1,647.15 |
Prescribed Olpruva?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.